X4 Pharmaceuticals (XFOR) director Bridger received 45,000 shares
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Gary Bridger (director at X4 Pharmaceuticals Inc., XFOR) reported that they received 45,000 shares on Jun 10, 2024. After these transactions the filing shows 96,667 shares held directly.
- Reporting person
- Bridger Gary
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jun 10, 2024 | Grant or award (A) | Common Stock1 | +45,000 | - | - | 96,667 direct |
Holdings before and after
- Common Stock: 51,667 to 96,667 direct
Footnotes from the filing
- 1. Represents restricted stock units (RSUs) granted to the Reporting Person as an annual award for service on the Board of Directors. The RSUs will vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the Issuer's next annual meeting of stockholders, subject to continued board service through the applicable vesting date. The RSUs will vest in full upon the occurrence of a change in control of the Issuer.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Bridger report in this XFOR Form 4?
Gary Bridger (director at X4 Pharmaceuticals Inc., XFOR) reported that they received 45,000 shares on Jun 10, 2024. After these transactions the filing shows 96,667 shares held directly.
How many XFOR shares does Bridger hold after this filing?
The filing shows 96,667 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for XFOR
Earlier insider filings at XFOR
- Jun 11, 2024Director Woods Keith was granted 45,000 shares, increasing direct ownership by 50% to 135,000 units (SEC Form 4)
- Jun 11, 2024Director Lawton Alison Frances was granted 45,000 shares, increasing direct ownership by 87% to 96,667 units (SEC Form 4)
- Jun 11, 2024Director Wyzga Michael S was granted 45,000 shares, increasing direct ownership by 59% to 121,667 units (SEC Form 4)
- Mar 11, 2024Taveras Arthur sold $12,552 worth of shares (14,235 units at $0.88), decreasing direct ownership by 6% to 234,301 units (SEC Form 4)
- Mar 11, 2024Ragan Paula sold $43,856 worth of shares (49,678 units at $0.88), decreasing direct ownership by 6% to 765,068 units (SEC Form 4)
Quantisnow market dataNASDAQ
XFOR
X4 Pharmaceuticals Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 2017
Get push alerts for XFOR
Full XFOR profile on Quantisnow Follow XFOR and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time